Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

[Aerosolized iloprost therapy for pulmonary hypertensive crisis in 4 patients with idiopathic pulmonary arterial hypertension].

Deng KW, Zhou YJ, Xu XQ, Wu MY, Wang GH, Bian H, Chen B, Wang CB.

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Oct;40(10):854-7. Chinese.

PMID:
23302674
2.

Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.

Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W.

Ann Intern Med. 1996 May 1;124(9):820-4.

PMID:
8610951
3.

Acute responses to inhalation of Iloprost in patients with pulmonary hypertension.

Zhang HL, Liu ZH, Wang Y, Xiong CM, Ni XH, He JG, Luo Q, Zhao ZH, Zhao Q, Sun XG.

Chin Med J (Engl). 2012 Aug;125(16):2826-31.

PMID:
22932074
4.

Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.

Opitz CF, Wensel R, Bettmann M, Schaffarczyk R, Linscheid M, Hetzer R, Ewert R.

Eur Heart J. 2003 Feb;24(4):356-65.

PMID:
12581683
5.

Aerosolized iloprost for postoperative pulmonary hypertensive crisis in children with congenital heart disease.

Limsuwan A, Wanitkul S, Khosithset A, Attanavanich S, Samankatiwat P.

Int J Cardiol. 2008 Oct 13;129(3):333-8. Epub 2007 Dec 21.

PMID:
18096256
6.

Aerosolized iloprost in CREST syndrome related pulmonary hypertension.

Launay D, Hachulla E, Hatron PY, Goullard L, Onimus T, Robin S, Fauchais AL, Queyrel V, Michon-Pasturel U, Hebbar M, Saulnier F, Devulder B.

J Rheumatol. 2001 Oct;28(10):2252-6.

PMID:
11669165
7.

[Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].

Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbrück B, Grimminger F, Seeger W.

Pneumologie. 2000 Mar;54(3):133-42. German.

PMID:
10783653
8.

Long-term treatment of pulmonary hypertension with aerosolized iloprost.

Machherndl S, Kneussl M, Baumgartner H, Schneider B, Petkov V, Schenk P, Lang IM.

Eur Respir J. 2001 Jan;17(1):8-13.

9.

[Effects of inhaled aerosolized iloprost in adult patients with pulmonary arterial hypertension on right heart functions].

Guo XX, Tian Z, Liu YT, Wang Q, Li MT, Zeng XF, Zhu WL, Fang Q.

Zhonghua Yi Xue Za Zhi. 2011 Nov 1;91(40):2832-6. Chinese.

PMID:
22333544
10.
11.

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

Ghofrani HA, Wiedemann R, Rose F, Olschewski H, Schermuly RT, Weissmann N, Seeger W, Grimminger F.

Ann Intern Med. 2002 Apr 2;136(7):515-22.

PMID:
11926786
12.

[Immediately effects of inhaled aerosolised iloprost in adult patients with severe pulmonary hypertension secondary to congenital heart diseases].

Zhang CJ, Huang YG, Shen JJ, Huang T, Huang WH, Cui YL, Huang XS.

Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Jan;39(1):65-8. Chinese.

PMID:
21418801
13.

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.

Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, Niedermeyer J, Fabel H, Seeger W.

J Am Coll Cardiol. 2000 Jan;35(1):176-82.

14.

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.

Wilkens H, Guth A, König J, Forestier N, Cremers B, Hennen B, Böhm M, Sybrecht GW.

Circulation. 2001 Sep 11;104(11):1218-22.

15.

Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.

Kramm T, Eberle B, Guth S, Mayer E.

Eur J Cardiothorac Surg. 2005 Dec;28(6):882-8. Epub 2005 Oct 19.

PMID:
16242948
16.

[Effects of iloprost combined with low dose tadalafil in adult congenital heart disease patients with severe pulmonary arterial hypertension: a single-center, open-label controlled study].

Zhang C, Huang Y, Huang T, Xia C, Huang X, Zhang G, Yao H, Chen J, Chen J, Wu S, Zhuang J.

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Jun;42(6):474-80. Chinese.

PMID:
25164220
17.

[The acute effects of inhaled iloprost on hemodynamics and oxygenation in chronic thromboembolic pulmonary hypertension].

Luo L, Yang YH, Cui N, Xie WM, Zhai ZG, Ma ZH, Wang C.

Zhonghua Yi Xue Za Zhi. 2009 Aug 11;89(30):2103-5. Chinese.

PMID:
20058612
18.

Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.

Yin N, Kaestle S, Yin J, Hentschel T, Pries AR, Kuppe H, Kuebler WM.

Crit Care Med. 2009 Mar;37(3):980-6. doi: 10.1097/CCM.0b013e3181962ce6.

PMID:
19237907
19.

Recovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost.

Olschewski H, Ghofrani HA, Walmrath D, Temmesfeld-Wollbrück B, Grimminger F, Seeger W.

Intensive Care Med. 1998 Jun;24(6):631-4.

PMID:
9681789
20.

Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension.

Zhang DZ, Zhu XY, Meng J, Xue HM, Sheng XT, Han XM, Cui CS, Wang QG, Zhang P.

Int J Cardiol. 2011 Mar 17;147(3):433-7. doi: 10.1016/j.ijcard.2010.04.093.

PMID:
20537740

Supplemental Content

Support Center